News

Smarter diabetes care at a distance: results of CloudCare

Living with type 1 diabetes doesn't pause between appointments. In our video interview, Sander Last, Head of Product & Solution, talks about CloudCare, the population health management platform developed by Diabeter. Below, we summarize what the first published study shows.

CloudCare is a CE-marked remote monitoring and triaging platform (registered as an MDR class IIa medical device) that was developed by Diabeter's clinicians. It collects glucose data every day from multiple sources, such as CareLink, Glooko and LibreView, and translates it into clinically relevant glycemic parameters. A color-coded heatmap shows the care team who is doing well and who needs attention. Patients see the same heatmap in their app, so both sides work from the same information.

For people whose glucose values stay on track, a detailed review of their data is not needed. Care teams can focus their time on those who need support, and visit schedules are agreed with each patient individually.

What the study looked at
In this prospective cohort study, published in BMC Endocrine Disorders (2025), adults with type 1 diabetes started CloudCare as part of their care at Diabeter. The first 6-month analysis covers 119 participants with complete follow-up. The median age was 29.9 years, 93% used an insulin pump, and glycemic control was already good at the start (median TIR 79%).

What this means for care
The study suggests that patients with well-controlled diabetes can be supported with fewer in-person visits, without losing glycemic control and with greater satisfaction. The researchers expect this to reduce the workload for healthcare professionals, although workload was not measured directly. In a healthcare system facing staff shortages, that makes data-driven, hybrid care pathways an important direction.

Watch the full interview below